Occupational stress trajectories and metabolic dysfunction-associated steatotic liver disease among female nurses: a prospective Cohort Study

被引:0
|
作者
Luo, Hanxiao [1 ,3 ]
Xing, Linlin [2 ]
Fu, Tongtong [1 ]
Xiao, Shiqi [1 ]
Fan, Ling [1 ,3 ]
机构
[1] China Med Univ, Dept Nursing, Shengjing Hosp, Shenyang, Liaoning, Peoples R China
[2] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China
[3] China Med Univ, Dept Nursing, Shenyang, Liaoning, Peoples R China
关键词
Occupational stress; Trajectory; MASLD; Cohort Study; FATTY LIVER; JOB STRAIN; METAANALYSIS; STATEMENT; DIAGNOSIS; HEALTH; RISK;
D O I
10.1186/s12889-024-20742-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prominent cause of chronic liver disease, and occupational stress may serve as a potential risk factor. This study aims to assess the association between occupational stress trajectories and incident MASLD among Chinese female nurses. Methods We conducted a prospective longitudinal study using data from the Nurse' Health Cohort Study, involving 1,113 female nurses, free of MASLD at baseline (2018). Occupational stress was measured using the Chinese Nurse Job Stress Scale at four time points. Group-based trajectory modeling was used to identify distinct stress trajectories. Through doctors' diagnoses, we assessed incident MASLD over a subsequent 6-year period from 2019 to 2024. Cox proportional hazards regression models evaluated the association of stress trajectories and MASLD risk, adjusting for demographics, work-related factors, and medical conditions. Results During follow-up, 256 nurses reported incident physician-diagnosed MASLD. Three occupational stress trajectories were identified: moderate decreasing (36.4%), moderate stable (55.9%), and moderate increasing (7.7%). Participants in the moderate increasing stress trajectory had a significantly higher risk of developing MASLD (adjusted HR: 3.14, 95% CI: 2.19-4.49, p < .001) compared to those in the moderate stable trajectory. This association between stress trajectory and MASLD risk was not modified by age or BMI (p(interaction)>0.50). Conclusions and relevance The study concludes that increasing stress levels over time are associated with a higher incidence of MASLD. These findings underscore the importance of stress management interventions in reducing the risk of MASLD progression. Further research is needed to explore the underlying mechanisms and to develop targeted strategies for stress reduction in clinical settings.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [2] Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
    Song, Ziping
    Miao, Xinlei
    Xie, Xiaoling
    Tang, Guimin
    Deng, Jiayi
    Hu, Manling
    Liu, Shuang
    Leng, Song
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [3] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
  • [4] Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: a prospective pilot study
    Tovoli, F.
    Stefanini, B.
    Mandrioli, D.
    Mattioli, S.
    Vornoli, A.
    Sgargi, D.
    Manservisi, F.
    Piscaglia, F.
    Curti, S.
    Bolondi, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S53 - S53
  • [5] Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study
    Tovoli, Francesco
    Stefanini, Bernardo
    Mandrioli, Daniele
    Mattioli, Stefano
    Vornoli, Andrea
    Sgargi, Daria
    Manservisi, Fabiana
    Piscaglia, Fabio
    Curti, Stefania
    Bolondi, Luigi
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (04) : 571 - 578
  • [6] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [7] Iron, Oxidative Stress, and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Gensluckner, Sophie
    Wernly, Bernhard
    Datz, Christian
    Aigner, Elmar
    ANTIOXIDANTS, 2024, 13 (02)
  • [8] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [9] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [10] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166